1-3 of 3
Keywords: Survival
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Metastasiertes Pankreaskarzinom: Chirurgen und Internisten müssen Kräfte bündeln: Wissenstransfer zu Ilmer M, Schiergens TS, Renz BW et al.: Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection. Surg Oncol. 2019 Aug 26;31:16-21. doi: 10.1016/j.suronc.2019.08.010.

Subject Area:
Oncology
Hans-Rudolf Raab
Journal: Kompass Onkologie
Kompass Onkol (2019) 6 (4): 213–215.
https://doi.org/10.1159/000504463
Published Online: 12 December 2019
.... Univariate survival analysis was performed. Results: We identified 15 patients undergoing pulmonary resection for suspected metastasis after primary pancreatic resection. Operative and histopathologic evaluation revealed resectable pancreatic pulmonary metastasis in 11 patients (73.3%). The median disease...
View article titled, Metastasiertes Pankreaskarzinom: Chirurgen und Internisten müssen Kräfte bündeln: Wissenstransfer zu Ilmer M, Schiergens TS, Renz BW et al.: Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection. Surg Oncol. 2019 Aug 26;31:16-21. doi: 10.1016/j.suronc.2019.08.010.
Open the PDF for Metastasiertes Pankreaskarzinom: Chirurgen und Internisten müssen Kräfte bündeln: Wissenstransfer zu Ilmer M, Schiergens TS, Renz BW et al.: Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection. Surg Oncol. 2019 Aug 26;31:16-21. doi: 10.1016/j.suronc.2019.08.010. in another window
Journal Articles

Der Charlson Comorbidity Score - eine Entscheidungshilfe bei der adjuvanten Therapie des fortgeschrittenen Endometriumkarzinoms: Wissenstransfer zu Ghanem AI, Modh A, Burmeister C et al.: Does Age-Adjusted Charlson Comorbidity Score Impact Survival Endpoints in Women with Federation of Gynecology and Obstetrics-Stage III Endometrial Cancer? Gynecol Obstet Invest. 2018;83:290-298.

Subject Area:
Oncology
Martin Pölcher
Journal: Kompass Onkologie
Kompass Onkol (2019) 6 (2): 96–97.
https://doi.org/10.1159/000500066
Published Online: 27 May 2019
...Martin Pölcher Objectives: We sought to evaluate the impact of age-adjusted Charlson comorbidity index (AACCI) score on survival endpoints for women with advanced stage endometrial carcinoma (EC). Methods and Materials: We identified 238 women with stage III EC. AACCI score was calculated and 3...
View article titled, Der Charlson Comorbidity Score - eine Entscheidungshilfe bei der adjuvanten Therapie des fortgeschrittenen Endometriumkarzinoms: Wissenstransfer zu Ghanem AI, Modh A, Burmeister C et al.: Does Age-Adjusted Charlson Comorbidity Score Impact <span class="search-highlight">Survival</span> Endpoints in Women with Federation of Gynecology and Obstetrics-Stage III Endometrial Cancer? Gynecol Obstet Invest. 2018;83:290-298.
Open the PDF for Der Charlson Comorbidity Score - eine Entscheidungshilfe bei der adjuvanten Therapie des fortgeschrittenen Endometriumkarzinoms: Wissenstransfer zu Ghanem AI, Modh A, Burmeister C et al.: Does Age-Adjusted Charlson Comorbidity Score Impact <span class="search-highlight">Survival</span> Endpoints in Women with Federation of Gynecology and Obstetrics-Stage III Endometrial Cancer? Gynecol Obstet Invest. 2018;83:290-298. in another window
Journal Articles

Gibt es Fortschritte in der Routinebehandlung von Patienten mit fortgeschrittenem Pankreaskarzinom?: Wissenstransfer zu Chakupurakal G, et al.: Oncol Res Treat 2017;40:784-788.

Subject Area:
Oncology
Michael Stahl
Journal: Kompass Onkologie
Kompass Onkol (2018) 5 (2): 94–95.
https://doi.org/10.1159/000486633
Published Online: 12 April 2018
... was the major modality of treatment (86%) with a median overall survival (OS) of 33.3 weeks (range 1.7-245.4 weeks). Chemotherapy significantly (p < 0.001) improved OS in comparison to best supportive care only (37.6 vs. 13.9 weeks). Patients with locally advanced disease had a better prognosis compared...
View article titled, Gibt es Fortschritte in der Routinebehandlung von Patienten mit fortgeschrittenem Pankreaskarzinom?: Wissenstransfer zu Chakupurakal G, et al.: Oncol Res Treat 2017;40:784-788.
Open the PDF for Gibt es Fortschritte in der Routinebehandlung von Patienten mit fortgeschrittenem Pankreaskarzinom?: Wissenstransfer zu Chakupurakal G, et al.: Oncol Res Treat 2017;40:784-788. in another window